These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6727568)

  • 1. Evidence for direct inhibitory effects of dopamine on zona glomerulosa secretion of 18-hydroxycorticosterone in rhesus monkeys.
    Sowers JR; Beck FW; Eggena P
    Life Sci; 1984 Jun; 34(24):2339-46. PubMed ID: 6727568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoid suppression enhances the 18-hydroxycorticosterone and aldosterone response to metoclopramide in man.
    Sowers JR; Beck FW; Stern N
    Life Sci; 1983 Dec; 33(25):2489-95. PubMed ID: 6645810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of metoclopramide and domperidone on aldosterone, 18-hydroxycorticosterone and prolactin secretion in the rhesus monkey.
    Sowers JR; Eggena P; Phillips D
    Metabolism; 1982 Dec; 31(12):1219-23. PubMed ID: 7144566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopaminergic regulation of 18-hydroxycorticosterone and aldosterone secretion in man.
    Sowers JR; Beck FW
    Acta Endocrinol (Copenh); 1983 Feb; 102(2):258-64. PubMed ID: 6338674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopaminergic modulation of aldosterone secretion in the rhesus monkey: evidence that dopamine affects the late pathway of aldosterone biosynthesis by inhibiting the conversion of corticosterone to 18-hydroxycorticosterone.
    Sowers JR; Berg G; Martin VS; Mayes DM
    Endocrinology; 1982 Apr; 110(4):1173-7. PubMed ID: 7060520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of corticosteroid secretion by dopaminergic mechanisms in rhesus monkeys.
    Sowers JR
    Am J Physiol; 1982 Nov; 243(5):E375-9. PubMed ID: 7137342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic modulation of 18-hydroxycorticosterone secretion in man.
    Sowers JR; Berg G; Tuck ML; Martin VI; Chandler DW; Mayes DM
    J Clin Endocrinol Metab; 1982 Mar; 54(3):523-7. PubMed ID: 7035483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of metoclopramide and dopamine on mineralocorticoid secretion--in vivo and in vitro studies].
    Ojima M; Itoh N; Kusano Y; Yaginuma K; Fukuchi S
    Nihon Naibunpi Gakkai Zasshi; 1986 Mar; 62(3):197-207. PubMed ID: 3709883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of sodium homeostasis and circadian rhythm on dopaminergic modulation of 18-hydroxycorticosterone secretion in man.
    Sowers JR; Stern N
    J Clin Endocrinol Metab; 1982 Dec; 55(6):1046-51. PubMed ID: 7130335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ganglionic blockade with trimethaphan on corticosteroid responses to metoclopramide in rhesus monkeys.
    Sowers JR; Beck FW; Eggena P
    J Hypertens; 1984 Aug; 2(4):367-70. PubMed ID: 6152278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of renin activation and regulation of aldosterone and 18-hydroxycorticosterone biosynthesis in hyporeninemic hypoaldosteronism.
    Sowers JR; Beck FW; Waters BK; Barrett JD; Welch BG
    J Clin Endocrinol Metab; 1985 Jul; 61(1):60-7. PubMed ID: 2987296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopaminergic modulation of corticosteroid responses to angiotensin II in man.
    Sowers JR; Beck FW
    Clin Exp Hypertens A; 1983; 5(5):651-64. PubMed ID: 6309435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of dopamine in the regulation of aldosterone and 18-hydroxycorticosterone secretion in man.
    Sowers JR; Beck FW
    J Endocrinol Invest; 1984 Oct; 7(5):473-9. PubMed ID: 6096435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of domperidone, an extracerebral inhibitor of dopamine receptors, on thyrotropin, prolactin, renin, aldosterone, and 18-hydroxycorticosterone secretion in man.
    Sowers JR; Sharp B; McCallum RW
    J Clin Endocrinol Metab; 1982 Apr; 54(4):869-71. PubMed ID: 7037817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma corticosteroids in hyperreninemic hypoaldosteronism: evidence for diffuse impairment of the zona glomerulosa.
    Stern N; Beck FW; Sowers JR; Tuck M; Hsueh WA; Zipser RD
    J Clin Endocrinol Metab; 1983 Jul; 57(1):217-20. PubMed ID: 6304133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine reduces aldosterone and 18-hydroxycorticosterone response to angiotensin II in patients with essential low-renin hypertension and idiopathic hyperaldosteronism.
    Witzgall H; Lorenz R; von Werder K; Weber PC
    Clin Sci (Lond); 1985 Mar; 68(3):291-9. PubMed ID: 3882312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of metoclopramide on plasma corticosteroid levels in sheep.
    Sowers JR; Beck FW; Stern N; Asp N
    Endocrinology; 1983 Sep; 113(3):903-6. PubMed ID: 6872958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of bromocriptine on the circadian rhythm of 18-hydroxycorticosterone and cortisol secretion in essential hypertensives.
    Sowers JR; Tuck ML; Beck FW; Stern N
    J Hypertens; 1983 Aug; 1(2):141-4. PubMed ID: 6681033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The natural history of salt-wasting disorders of adrenal and renal origin.
    Rösler A
    J Clin Endocrinol Metab; 1984 Oct; 59(4):689-700. PubMed ID: 6384251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The constant plasma 18-hydroxycorticosterone to aldosterone ratio: an expression of the efficacy of corticosterone methyloxidase type II activity in disorders with variable aldosterone production.
    Kater CE; Biglieri EG; Rost CR; Schambelan M; Hirai J; Chang BC; Brust N
    J Clin Endocrinol Metab; 1985 Feb; 60(2):225-8. PubMed ID: 2981240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.